Patient Rating:

No Rating Available?

Lyska L. Emerson, M.D.

Patient Rating:

No Rating Available?

Specialties

Languages

  • English

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 581-2507 Huntsman Cancer Hospital
1950 Circle of Hope
Salt Lake City, UT 84112
Map

Specialties

Bio

Dr. Emerson's service work is predominantly in general surgical pathology with a subspecialty interest in pulmonary pathology. Her research efforts are currently in the area of pancreatic-cancer research and various collaborative translational medicine projects.

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Anatomic Pathology
Board Certification American Board of Pathology (Anatomic)

Academic Profile

Board Certification and Academic Information

Academic Departments Pathology - Associate Professor (Clinical)
Academic Divisions Anatomic Pathology
Board Certification American Board of Pathology (Anatomic)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-2507 Huntsman Cancer Hospital
Surgical Pathology
1950 Circle of Hope
Salt Lake City, UT 84112

Academic Bio

Dr. Emerson is an Associate Professor in the Department of Pathology, Division of Anatomic Pathology, and serves as a consultant for ARUP Laboratories’ clients. Dr. Emerson received her medical degree from the University of Texas Health Sciences Center at Houston and served a combined residency in anatomic and clinical pathology at the University of New Mexico Health Sciences Center and University of Texas Health Sciences Center at Houston. She completed her fellowship in general surgical pathology at the University of Utah School of Medicine in 2001. She is board certified by the American Board of Pathology in anatomic pathology and is a member of the United States and Canadian Academy of Pathology, American Society for Clinical Pathology (fellow), and the Huntsman-Intermountain Cancer Care Program.

Education

Education History

Type School Degree
Fellowship University of Utah School of Medicine
Surgical Pathology
Fellow
Residency University of Texas Health Science Center at Houston
Pathology
Resident
Residency University of New Mexico Health Sciences Center
Pathology
Resident
Professional Medical University of Texas Health Science Center at Houston
Medicine
M.D.
Undergraduate Baylor University
Science
B.S.

Publications

Selected Provider Publications

Journal Article

  1. Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, Mulvihill SJ (2013). Serum Osteopontin and Tissue Inhibitor of Metalloproteinase 1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma. Pancreas, 42(2), 193-7.
  2. Luo L, Zhang X, Hirano Y, Tyagi P, Barabas P, Uehara H, Miya TR, Singh N, Archer B, Qazi Y, Jackman K, Das S, Olsen T, Chennamaneni RS, Stagg B, Ahmed F, Emerson LL, Zygmunt K, Whitaker R, Mamalis C, Huang W, Gao G, Srinivas S, Krizaj D, Baffi JZ, Ambati J, Kompella UB, Ambati BK (2013). Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. ACS Nano, 7(4), 3264-75.
  3. Kulke MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer MA (2012). National Comprehensive Cancer Networks. J Natl Compr Canc Netw, 10(6), 724-64.
  4. Emerson LL, Layfield LJ (2012). Solitary Peripheral Pulmonary Papilloma Evaluation on Frozen Section: A Potential Pitfall for the Pathologist. Pathol Res Pract, 208(2012), 726-729.
  5. Goldfarb-Rumyantzev AS, Wright S, Ragasa R, Ostler D, Van Orden J, Smith L, Efimova E, Emerson L, Sandhu GS, Shihab F (2011). Factors associated with nonadherence to medication in kidney transplant recipients. Nephron Clinical Practice, 117(1), c33-9.
  6. Wallander ML, Emerson LL, Tripp S, Davis D, Mamalis N, Holden JA, Layfield LJ (August 2011). KIT and PDGFRA Mutations in Ocular Melanoma: Frequency and Anatomic Distribution. Mod Pathol, 24(8), 1031-5.
  7. Alkhatib AA, Craig R, Tuteja AK, Emerson LL (2010). Progression of solitary rectal ulcer syndrome over a 2-year period. Gastrointest Endosc, 72(4), 853-4.
  8. Scaife CL, Shea J, Emerson L, Boucher K, Firpo MA, Beckerle MC, Mulvihill SJ (2010). Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma. HPB (Oxford), 12(5), 352-8.
  9. Poruk KE, Firpo MA, Huerter LM, Scaife CL, Emerson LL, Boucher KM, Jones KA, Mulvihill SJ (2010). Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev, 19(10), 2605-10.
  10. Wu X, Jeong EK, Emerson L, Hoffman J, Parker DL, Lu ZR (2010). Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers. Mol Pharm, 7(1), 41-8.
  11. Fang WS, Emerson LL, Hunt JP, Salzman KL (2009). An unusual sinonasal tumor: soft tissue perineurioma. AJNR Am J Neuroradiol, 30(2), 437-9.
  12. Goldfarb-Rumyantzev AS, Shihab F, Emerson L, Mineau G, Schaefer C, Tang H, Hunter C, Naiman N, Smith L, Kerber R (2009). A population-based assessment of the familial component of acute kidney allograft rejection. Nephrol Dial Transplant, 24(8), 2575-83.
  13. Peterson KA, Thomas KL, Hilden K, Emerson LL, Wills JC, Fang JC (2009). Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis. Dig Dis Sci.
  14. Wu X, Feng Y, Jeong EK, Emerson L, Lu ZR (2009). Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice. Pharm Res, 26(9), 2202-8.
  15. Feng Y, Emerson L, Jeong EK, Parker DL, Lu ZR (2009). Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy. J Magn Reson Imaging, 30(2), 401-6.
  16. Wallander M, Layfield LJ, Jarboe E, Emerson L, Liu T, Thaker H, Holden J, Tripp S (2009). Follicular Variant of Papillary Carcinoma: Reproducibility of Histologic Diagnosis and Utility of HBME-1 Immunohistochemistry and BRAF Mutational Analysis as Diagnostic Adjuncts. Appl Immunohistochem Mol Morphol.
  17. Schwartz JL, Woods B, Emerson L, Andtbacka R (2009). Appendiceal adenocarcinoma arising after bone marrow transplantation for Non-Hodgkin Lymphoma: an unusual treatment dilemma. Internet Journal of Oncology, The, (6), 1.
  18. Vaidya A, Sun Y, Feng Y, Emerson L, Jeong EK, Lu ZR (2008). Contrast-Enhanced MRI-Guided Photodynamic Cancer Therapy with a Pegylated Bifunctional Polymer Conjugate. Pharm Res, 25(9), 2002-11.
  19. Emerson LL, Carney HM, Layfield LJ, Sherbotie JR (2008). Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hybridization study. Pediatr Transplant, 12(5), 600-5.
  20. Feng Y, Jeong EK, Mohs AM, Emerson L, Lu ZR (2008). Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice. Magn Reson Med, 60(6), 1347-52.
  21. De La O JP, Emerson LL, Goodman JL, Froebe SC, Illum BE, Curtis AB, Murtaugh LC (2008). Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A, 105(48), 18907-12.
  22. Layfield LJ, Emerson L, Crim JR, Randall L (2008). Squamous differentiation and cytokeratin expression in an osteosarcoma: a case report and review of the literature. Clin Med Pathol, 1, 55-9.
  23. Goulet CJ, Disario JA, Emerson L, Hilden K, Holubkov R, Fang JC (2007). In vivo evaluation of argon plasma coagulation in a porcine model. Gastrointest Endosc, 65(3), 457-62.
  24. Mohs AM, Nguyen T, Jeong EK, Feng Y, Emerson L, Zong Y, Parker DL, Lu ZR (2007). Modification of Gd-DTPA cystine copolymers with PEG-1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography. Magn Reson Med, 58(1), 110-8.
  25. Rowe LR, Mulvihill SJ, Emerson L, Gopez EV (2007). Subcutaneous tumor seeding following needle core biopsy of hepatocellular carcinoma. Diagn Cytopathol, 35(11), 717-21.
  26. Yu M, Miller ME, Emerson L, Bentz BG, Clayton F, Data RE, Salzman KL, and Smith LM (October 2007). An Unusual case of an extraosseus ewing's sarcoma. J Clin Oncol, 25(30), 4845-8.
  27. Emerson LL, Layfield LJ, and Frame R (Sep 2007). Pleomorphic olfactory neuroblastoma (esthesioneuroblastoma): histopathologic findings and clinical course. Histopathology, 51(3), 430-432.
  28. Emerson LL, Tripp SR, Baird BC, Layfield LJ, Rohr LR (2006). A comparison of immunohistochemical stain quality in conventional and rapid microwave processed tissues. Am J Clin Pathol, 125(2), 176-83.
  29. Rollins MD, Sudarshan S, Firpo MA, Etherington BH, Hart BJ, Jackson HH, Jackson JD, Emerson LL, Yang DT, Mulvihill SJ, Glasgow RE (2006). Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. J Gastrointest Surg, 10(8), 1120-30.
  30. Tanaka R, Emerson LL, Karwande SV, Schreiker G (2005). Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker. Chest, 127(5), 1848-51.
  31. Emerson L, Layfield L, Rohr R, Dayton M (2004). Adenocarcinoma Arising in Association with Gastric Heterotopic Pancreas: A Case Report and Review of the Literature. J Surg Oncol, 87(1), 53-57.
  32. Emerson L, Layfield L, Reiss R, Mulvihill S (2001). Malignant Islet Cell Tumor with Sarcomatous Differentiation. Mod Pathol, 14(11), 1187-91.
  33. Dasgupta A, Emerson L (1998). Neutralization of cardiac toxins oleandrin, oleandrigenin, bufalin, and cinobufotalin by digibind: monitoring the effect by measuring free digitoxin concentrations. Life Sci, 63(9), 781-8.
  34. Dasgupta A, Emerson L (1996). Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: lack of interaction in uremic sera due to the presence of endogenous factors. Ther Drug Monit, 18(6), 654-9.
  35. Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, Lowichik A, Chen X, Emerson L, Cox K, OGorman MA, Peterson KA (In Press). Adult Eosinophilic Esophagitis is IgG4-Associated Rather Than IgE-Mediated: A Randomized Omalizumab Trial. Gastroenterology.

Abstract

  1. Farkash E, Brousaides N, Nickeleit V, Papadimitriou J, Roberts IS, Emerson L, Pelle TD, McDaid J, Colvin R (2014). T Antigen Dependent Oncogenic Pathways are Active in Post-Transplant Tumors Driven by BK Polyoma Virus. 2014 World Transplant Congress, San Francisco, CA, Jul 26-31, 2014 [Abstract].
  2. Hewitt K, Shea J, Johnston WC, Emerson L, Scaife C (2013). PINCH Expression in Pancreatic Neuroendocrine Tumors. 47th Annual Pancreas Club Meeting, Orlando, FL. May 17-18, 2013 [Abstract].
  3. Fang JC, Hilden K, Gleich G, Emerson LL (2011). A Pilot Study of the Treatment of Eosinophilic Esophagitis with Omalizumab, Digestive Disease Week, Chicago, IL, May 7-10, 2011 [Abstract].
  4. Wallander ML, Layfield LJ, Emerson LL, Mamalis N, Davis D, Holden JA (2011). KIT Mutations in Ocular Melanoma. USCAP, San Antonio, TX, February 26 - March 4, 2011 [Abstract].
  5. Firpo MA, Shea JE, Brown K, Emerson L, Boucher KM, Scaife CL, Mulvihill SJ (2011). Serum MMP-7 is an Independent Predictor of Survival in Patients with Pancreatic Adenocarcinoma. Eleventh Annual Americas Hepato-Pancreato-Biliary Congress, Miami Beach, FL [Abstract]. HPB, 13(Suppl 1), 21.
  6. Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Bourcher KM, Mulvihill SJ (2011). Serum Osteopontin and TIMP-1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma Pancreas [Abstract]. 40, 1348-9.
  7. Poruk KE, Scaife CL, Emerson LL, Boucher KM, Firpo MA, Mulvihill SJ (2010). Serum platelet factor 4 is an independent predictor of survival in patients with pancreatic adenocarcinoma. American Surgical Congress, San Antonio, TX. Feb 3-5, 2010 [Abstract].
  8. Naiman N, Kerber R, Emerson L, Goldfarb A, Tang H, Smith L, Ostler D, Mineau G, Schaefer C, Shihab F (2009). A population-based assessment of the familial component of acute kidney allograft rejection [Abstract]. ASN Renal Week, San Diego, CA. October 27- November 1.
  9. Shea JE, Emerson LL, Scaife CL (2009). Metastatic tumors express greater levels of pinch [Abstract]. 43rd Annual Pancreas Club Meeting, Chicago, IL. May 30-31.
  10. Feng Y, Jeong EK, Emerson L, Lu ZR (2008). Assess tumor acute response to photothermal therapies by DCE-MRI using biodegradable macromolecule contrast agent [Abstract]. International Society of Magnetic Resonance in Medicine 16th Annual Scientific Meeting and Exhibition, Toronto, Ontario. May 3-9.
  11. Majer M, Gray P, Li X, Emerson LL, Kuwada SK (2008). Conditional deletion of Erbb2/Neu inhibits pancreatic tumorigenesis [Abstract]. Digestive Disease Week Conference, San Diego, CA. May 17-21.
  12. Fang JC, Emerson LL, Hilden K, Thomas KL, Peterson KA (2007). Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis [Abstract]. International Eosinophil Society, 5th Biennial Symposium, Snowbird, Utah. July18-22.
  13. Stafforini DM, Reichert E, Gardner A, Meikle W, Emerson L (2007). Deletion of platelet-activating factor acetylhydrolase (phospholipase A2 Group VII) increases the severity of prostate cancer and reduces life-span in the TRAMP model of prostate carcinogenesis [Abstract]. Department of Defense Prostate Cancer Research Program Meeting, Atlanta, GA. September 5-8.
  14. Feng Y, Jeong EK, Mohs AM, Emerson L, Lu ZR (2005). Polydisulfide-based biodegradable macromolecular contrast agents for dynamic contrast enhanced MRI: first experience with human prostate cancer xenograft [Abstract]. International Society of Magnetic Resonance in Medicine 15th Annual Scientific Meeting and Exhibition, Berlin, Germany May 19-25.
  15. Goulet CJ, Fang JC, Emerson L, Disario JA (2004). In Vitro Evaluation of Different Modes of Argon Plasma Coagulation in a Porcine Colon [Abstract]. American College of Gastroenterology 69th Annual Scientific Meeting.
  16. Jones RG, Peterson KA, Emerson LL (2004). Unusual Gastric Mass [Abstract]. American College of Gastroenterology 69th Annual Scientific Meeting.
  17. Rollins MD, Jackson HH, Emerson LL, Mulvihil SJ, Firpo MA, Glasgow RE (2003). Peroxisome proliferator-activated receptor-gamma agonists decrease the severity of acute pancreatitis. Awarded best basic science presentation [Abstract]. American Hepato-Pancreato-Biliary Association 4th America's Congress.

Other

  1. Emerson L, Chadwick BE (2008). Cytologic diagnosis of lymphoid lesions of the thyroid gland. Am Soc Clin Pathol Check Sample Series.
  2. Layfield L, Emerson L (2002). Hepatic Bile Duct Cystadenoma: A Case Report and Review of the Literature. ARUP Path Elec J.
  3. Layfield L, Gopez E, Emerson L (2002). Mediastinal Hemangiolymphangioma: Fine-Needle Aspiration Findings in a Rare Mediastinal Tumor. ARUP Path Elec J.
  4. Layfield L, Emerson L (2002). Spindle Cell Predominant Malignant Neuroepithelial Tumor of Kidney. ARUP Path Elec J.

Clinical Trials

Video & News